Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Grazax Compliance with Memozax Device
NCT00293046Phase 3Completed
- Sponsor
- ALK-Abelló
- Start
- Feb 2006
- Primary completion
- Sep 2006
- Modality
- Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of grass-pollen extract in allergic rhinoconjunctivitis (ARC), sponsored by ALK-Abelló. Started Feb 2006; status: completed.
02
Drugs
grass-pollen extract
03
Conditions
allergic rhinoconjunctivitis (ARC)
Beyond the preview
Go deeper on NCT00293046.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00293046.